Myla Lai-Goldman
Fortune : 6 M $ au 31/05/2026
Fortune : 6 M $ au 31/05/2026
Myla P.
Lai-Goldman was the founder of CancerGuide Diagnostics, Inc., founded in 2009, where the title held was Chief Executive & Scientific Officer from 2009 to 2010.
Dr. Lai-Goldman is the founder of GeneCentric Therapeutics, Inc., founded in 2011, holding the title of Executive Chairman since 2019.
Dr. Lai-Goldman is the founder of Personalized Science LLC, founded in 2009, serving as Managing Partner since 2009.
Current jobs include Independent Director at West Pharmaceutical Services, Inc. since 2015, Director at Council for Entrepreneurial Development, Director at NovoPath LLC since 2022, Independent Director at Quanterix Corp.
starting 2025, Director at Qvella Corp., Director at Mercy BioAnalytics, Inc. since 2023, and Venture Partner at Hatteras Venture Partners since 2011.
Former jobs include Independent Director at Sequenom, Inc. from 2013 to 2016, Medical Director at Center for Molecular Biology & Pathology from 1991 to 2004, Independent Director at Akoya Biosciences, Inc. from 2021 to 2025, Executive VP, Chief Medical & Scientific Officer at Laboratory Corporation of America Holdings from 1991 to 2008, Executive VP, Chief Medical & Scientific Officer at Roche Biomedical Laboratories, Inc., Principal at National Genetics Institute, Inc., and Principal at Viro-Med Laboratories, Inc. Education includes a doctorate from The Trustees of Columbia University in The City of New York conferred in 1983 and an undergraduate degree from the University of Pennsylvania conferred in 1979.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 19 424 ( 0,03 % ) | 6 M $ | 31/05/2026 | |
QUANTERIX CORPORATION 0,01 % | 15/04/2026 | 6 968 ( 0,01 % ) | 21 322 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Directeur/Membre du Conseil | 17/02/2014 |
| QUANTERIX CORPORATION | Directeur/Membre du Conseil | 08/07/2025 |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Private Equity Investor | 01/08/2011 |
NovoPath LLC
NovoPath LLC Packaged SoftwareTechnology Services Develops SaaS-based platform enables pathology labs around the world to automate, track, simplify and complete cases faster | Directeur/Membre du Conseil | 01/01/2022 |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Directeur/Membre du Conseil | - |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer detection products | Directeur/Membre du Conseil | 24/04/2023 |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers | Directeur/Membre du Conseil | - |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Fondateur | 01/01/2011 |
Personalized Science LLC
Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services for healthcare | Fondateur | 01/01/2009 |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 19 |
|---|---|
Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings Medical/Nursing ServicesHealth Services Provides laboratory services | Health Services |
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Sequenom, Inc.
Sequenom, Inc. Medical/Nursing ServicesHealth Services Provides genomic and genetic analysis solutions | Health Services |
Quanterix Corp.
Quanterix Corp. Medical SpecialtiesHealth Technology Develops and sells protein biomarker instruments that identify signatures in blood & tissue to provide insights to providers, patients and research organizations | Health Technology |
CancerGuide Diagnostics, Inc.
CancerGuide Diagnostics, Inc. Medical/Nursing ServicesHealth Services Develops and markets tests to support individualized cancer therapy decisions | Health Services |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. BiotechnologyHealth Technology Operates as an oncology company transforming cancer diagnostics and genomic profiling through the power of gene expression | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Biomedical Laboratories, Inc.
Roche Biomedical Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Provides bioomedical products | Health Technology |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Provides hepatitis C testing and other laboratory services | Process Industries |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, healthcare IT and human medicine. It provides financing for seed and early stage capital requirements and also makes co-investments. | Finance |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers | Commercial Services |
Viro-Med Laboratories, Inc.
Viro-Med Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides diagnostic testing in virology | Commercial Services |
Center for Molecular Biology & Pathology | |
Personalized Science LLC
Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services for healthcare | Commercial Services |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Akoya Biosciences, Inc.
Akoya Biosciences, Inc. BiotechnologyHealth Technology Develops a novel high-parameter tissue analysis platform | Health Technology |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer detection products | Health Technology |
NovoPath LLC
NovoPath LLC Packaged SoftwareTechnology Services Develops SaaS-based platform enables pathology labs around the world to automate, track, simplify and complete cases faster | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national